August 5, 2022
Lincoln, NE. LI-COR, a leading developer of environmental and biotech products, is pleased to announce the appointment of Jim Gould as its new Chief Financial Officer.
Tom Reslewic, CEO of LI-COR, said “We’re very excited to have Jim on board. His depth of experience, knowledge, and management capabilities will complement our team of seasoned executives.” Mr. Gould will join Scott Weekley, Chief Operations Officer, Kristin Feese, VP & General Manager, Environmental, and Bambi Reynolds, VP & General Manager, Biotechnology, on LI-COR’s leadership team.
Mr. Gould is an experienced financial executive with more than 30 years of diverse experience leading accounting, finance and other management functions across multiple industries and ownership structures. Prior to joining LI-COR, Mr. Gould led the Accounting, Finance, Human Resources and Information Technology functions at ANR Holdings, LLC, a contract manufacturer serving the beauty and personal care industry. During his time at ANR, he led multiple acquisition transactions and integration activities that substantially expanded the company’s geographic footprint and service capabilities. He also previously led the finance function at CSG, a global software and services provider. Mr. Gould holds a Bachelor of Science in Business Administration and a Master of Professional Accountancy from UNL.
About LI-COR Biosciences. LI-COR Biosciences is a leading innovator in the development of high-quality instrument systems used for plant research, gas analysis, drug discovery, protein research, and small animal imaging. The company’s instruments, analysis software, and reagents are used in more than one hundred countries, including the International Space Station, for studies ranging from global climate change to cancer research. LI-COR employs more than 300 employees at its headquarters in Lincoln, NE, USA, and subsidiaries in Bad Homburg, Germany, and Cambridge, UK. For more information, visit www.licor.com.